Cargando…

The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis

BACKGROUND: The optimal timing of initiating renal replacement therapy (RRT) in critical illness complicated by acute kidney injury (AKI) is not clearly established. Trials completed on this topic have been marked by contradictory findings as well as quality and heterogeneity issues. Our goal was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wierstra, Benjamin T., Kadri, Sameer, Alomar, Soha, Burbano, Ximena, Barrisford, Glen W., Kao, Raymond L. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858821/
https://www.ncbi.nlm.nih.gov/pubmed/27149861
http://dx.doi.org/10.1186/s13054-016-1291-8
_version_ 1782430860973178880
author Wierstra, Benjamin T.
Kadri, Sameer
Alomar, Soha
Burbano, Ximena
Barrisford, Glen W.
Kao, Raymond L. C.
author_facet Wierstra, Benjamin T.
Kadri, Sameer
Alomar, Soha
Burbano, Ximena
Barrisford, Glen W.
Kao, Raymond L. C.
author_sort Wierstra, Benjamin T.
collection PubMed
description BACKGROUND: The optimal timing of initiating renal replacement therapy (RRT) in critical illness complicated by acute kidney injury (AKI) is not clearly established. Trials completed on this topic have been marked by contradictory findings as well as quality and heterogeneity issues. Our goal was to perform a synthesis of the evidence regarding the impact of “early” versus “late” RRT in critically ill patients with AKI, focusing on the highest-quality research on this topic. METHODS: A literature search using the PubMed and Embase databases was completed to identify studies involving critically ill adult patients with AKI who received hemodialysis according to “early” versus “late”/“standard” criteria. The highest-quality studies were selected for meta-analysis. The primary outcome of interest was mortality at 1 month (composite of 28- and 30-day mortality). Secondary outcomes evaluated included intensive care unit (ICU) and hospital length of stay (LOS). RESULTS: Thirty-six studies (seven randomized controlled trials, ten prospective cohorts, and nineteen retrospective cohorts) were identified for detailed evaluation. Nine studies involving 1042 patients were considered to be of high quality and were included for quantitative analysis. No survival advantage was found with “early” RRT among high-quality studies with an OR of 0.665 (95 % CI 0.384–1.153, p = 0.146). Subgroup analysis by reason for ICU admission (surgical/medical) or definition of “early” (time/biochemical) showed no evidence of survival advantage. No significant differences were observed in ICU or hospital LOS among high-quality studies. CONCLUSIONS: Our conclusion based on this evidence synthesis is that “early” initiation of RRT in critical illness complicated by AKI does not improve patient survival or confer reductions in ICU or hospital LOS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-016-1291-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4858821
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48588212016-05-07 The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis Wierstra, Benjamin T. Kadri, Sameer Alomar, Soha Burbano, Ximena Barrisford, Glen W. Kao, Raymond L. C. Crit Care Research BACKGROUND: The optimal timing of initiating renal replacement therapy (RRT) in critical illness complicated by acute kidney injury (AKI) is not clearly established. Trials completed on this topic have been marked by contradictory findings as well as quality and heterogeneity issues. Our goal was to perform a synthesis of the evidence regarding the impact of “early” versus “late” RRT in critically ill patients with AKI, focusing on the highest-quality research on this topic. METHODS: A literature search using the PubMed and Embase databases was completed to identify studies involving critically ill adult patients with AKI who received hemodialysis according to “early” versus “late”/“standard” criteria. The highest-quality studies were selected for meta-analysis. The primary outcome of interest was mortality at 1 month (composite of 28- and 30-day mortality). Secondary outcomes evaluated included intensive care unit (ICU) and hospital length of stay (LOS). RESULTS: Thirty-six studies (seven randomized controlled trials, ten prospective cohorts, and nineteen retrospective cohorts) were identified for detailed evaluation. Nine studies involving 1042 patients were considered to be of high quality and were included for quantitative analysis. No survival advantage was found with “early” RRT among high-quality studies with an OR of 0.665 (95 % CI 0.384–1.153, p = 0.146). Subgroup analysis by reason for ICU admission (surgical/medical) or definition of “early” (time/biochemical) showed no evidence of survival advantage. No significant differences were observed in ICU or hospital LOS among high-quality studies. CONCLUSIONS: Our conclusion based on this evidence synthesis is that “early” initiation of RRT in critical illness complicated by AKI does not improve patient survival or confer reductions in ICU or hospital LOS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-016-1291-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-06 2016 /pmc/articles/PMC4858821/ /pubmed/27149861 http://dx.doi.org/10.1186/s13054-016-1291-8 Text en © Wierstra et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wierstra, Benjamin T.
Kadri, Sameer
Alomar, Soha
Burbano, Ximena
Barrisford, Glen W.
Kao, Raymond L. C.
The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis
title The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis
title_full The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis
title_fullStr The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis
title_full_unstemmed The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis
title_short The impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis
title_sort impact of “early” versus “late” initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858821/
https://www.ncbi.nlm.nih.gov/pubmed/27149861
http://dx.doi.org/10.1186/s13054-016-1291-8
work_keys_str_mv AT wierstrabenjamint theimpactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT kadrisameer theimpactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT alomarsoha theimpactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT burbanoximena theimpactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT barrisfordglenw theimpactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT kaoraymondlc theimpactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT wierstrabenjamint impactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT kadrisameer impactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT alomarsoha impactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT burbanoximena impactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT barrisfordglenw impactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis
AT kaoraymondlc impactofearlyversuslateinitiationofrenalreplacementtherapyincriticalcarepatientswithacutekidneyinjuryasystematicreviewandevidencesynthesis